Table 5.
NMF scores according to time—postpartum period and general (for all times) for individual HMOs.
| Days Postpartum | ||||
|---|---|---|---|---|
| HMOs | 2–8 (n = 52) | 28–50 (n = 75) | 88–119 (n = 46) | All Women (n = 101) |
| Fucosylated or Sialylated Lactose | ||||
| 2′FL | 0.38 | 0.37 | 1.00 | 0.80 |
| 3FL | 0.36 | 0.74 | 0.89 | 0.01 |
| DFLac | 0.03 | 0.06 | 0.10 | 0.02 |
| 3′SL | 0.05 | 0.15 | 0.03 | 0.01 |
| 6′SL | 0.42 | 0.12 | 0.10 | 0.29 |
| Non-Fucosylated, Non-Sialylated HMOs | ||||
| LNT | 0.48 | 0.27 | 0.03 | 0.14 |
| LNnT | 0.37 | 0.04 | 0.41 | 0.89 |
| LNH | 0.38 | 0.11 | 0.13 | 0.28 |
| Fucosylated, Non-Sialylated HMOs | ||||
| LNFP I | 0.41 | 0.62 | 0.76 | 0.43 |
| LNFP II | 0.53 | 0.30 | 0.16 | 0.14 |
| LNFP III | 0.03 | 0.04 | 0.09 | 0.70 |
| DFLNT | 0.44 | 0.51 | 0.45 | 0.46 |
| FLNH | 0.10 | 0.05 | 0.01 | 0.43 |
| DFLNH | 0.27 | 0.38 | 0.38 | 0.35 |
| Fucosylated, Non-Sialylated HMOs | ||||
| LSTb | 0.45 | 0.07 | 0.13 | 0.12 |
| LSTc | 0.08 | 0.01 | 0.05 | 0.84 |
| DSLNT | 0.37 | 0.03 | 0.48 | 0.39 |
| DSLNH | 0.38 | 0.04 | 0.19 | 0.37 |
| Fucosylated, Sialylated HMOs | ||||
| FDSLNH | 0.48 | 0.31 | 0.57 | 0.38 |
NMF scores represent the probability of contribution to (and importance of) a specified HMO variable to the basis component. HMO: human milk oligosaccharide. 2′FL: 2′-fucosyllactose. 3FL: 3-fucosyllactose. LNnT: lacto-N-neotetraose. 3′SL: 3′-sialyllactose. DFLac: difucosyllactose. 6′SL: 6′-sialyllactose. LNT: lacto-N-tetrose. LNFP: lacto-N-fucopentaose. LSTb: sialyl-lacto-N-tetraose b. LSTc: sialyl-lacto-N-tetraose c. DFLNT: difucosyllacto-N-tetrose. LNH: lacto-N-hexaose. DSLNT: disialyllacto-Ntetraose. FLNH: fucosyllacto-N-hexaose. DFLNH: difucosyllacto-N-hexaose. FDSLNH: fucodisialyllacto-N-hexaose. DSLNH: disialyllacto-N-hexaose.